These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15969985)

  • 1. Gemcitabine radiosensitization for rectal cancer: step forward or dance step?
    O'Neil BH; Tepper JE
    Cancer J; 2005; 11(2):110-2. PubMed ID: 15969985
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial.
    Allal AS; Bieri S; Gervaz P; Soravia C; Bernier J; Gertsch P; Morel P; Roth AD
    Cancer J; 2005; 11(2):133-9. PubMed ID: 15969988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.
    Corvò R; Pastrone I; Scolaro T; Marcenaro M; Berretta L; Chiara S
    Tumori; 2003; 89(4):361-7. PubMed ID: 14606636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
    Créhange G; Bosset JF; Maingon P
    Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiation with novel agents for rectal cancer.
    McMullen KP; Blackstock AW
    Clin Colorectal Cancer; 2002 May; 2(1):24-30. PubMed ID: 12453333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gemcitabine: a new chemotherapy agent for solid cancers].
    Klastersky J; Awada A
    Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "The best-laid plans ... often go awry ...".
    Urbanic JJ; Lally B; Blackstock AW
    J Thorac Oncol; 2009 Jul; 4(7):783-4. PubMed ID: 19550240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
    Azria D; Coelho M; Larbouret C; Lemanski C; Serre A; Ychou M; Pèlegrin A; Dubois JB; Culine S
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S106-13. PubMed ID: 15679255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer.
    Zhu AX; Willett CG
    Semin Radiat Oncol; 2003 Oct; 13(4):454-68. PubMed ID: 14586834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
    Krishnan S; Janjan NA; Skibber JM; Rodriguez-Bigas MA; Wolff RA; Das P; Delclos ME; Chang GJ; Hoff PM; Eng C; Brown TD; Crane CH; Feig BW; Morris J; Vadhan-Raj S; Hamilton SR; Lin EH
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):762-71. PubMed ID: 17011451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences.
    Suh WW; Schott AF; Hayman JA; Schipper MJ; Shewach DS; Pierce LJ
    Breast J; 2004; 10(3):204-10. PubMed ID: 15125746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Severe Rectal Hemorrhage Possibly Caused by Radiation Recall after Administration of Gemcitabine.
    Nishimoto K; Akise Y; Miyazawa M; Kutsuki S; Hashimoto S; Uchida A
    Keio J Med; 2016; 65(1):16-20. PubMed ID: 27040885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer.
    Swellengrebel HA; Marijnen CA; Verwaal VJ; Vincent A; Heuff G; Gerhards MF; van Geloven AA; van Tets WF; Verheij M; Cats A
    Br J Surg; 2011 Mar; 98(3):418-26. PubMed ID: 21254020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
    Herman JM; Smith DC; Montie J; Hayman JA; Sullivan MA; Kent E; Griffith KA; Esper P; Sandler HM
    Urology; 2004 Jul; 64(1):69-73. PubMed ID: 15245938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined systemic therapy and radiotherapy for bladder cancer.
    Rödel C; Weiss C; Sauer R
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():29-31. PubMed ID: 18167005
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.
    Trodella L; D'Angelillo RM; Ramella S; Cellini F; Ciresa M; Cesario A; Granone P
    Ann Oncol; 2006 May; 17 Suppl 5():v52-4. PubMed ID: 16807463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine-mediated radiosensitization.
    Lawrence TS; Eisbruch A; Shewach DS
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-24-S7-28. PubMed ID: 9194476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine-induced radiation recall dermatitis: case report.
    Bar-Sela G; Beny A; Bergman R; Kuten A
    Tumori; 2001; 87(6):428-30. PubMed ID: 11989599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer.
    Choi B; Robins HI; Schiller J; Mehta M
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):175-9. PubMed ID: 18305938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.